(Q73638685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

hepatocellular carcinoma

1 reference

Mariana Capurro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ian R Wanless

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Morris Sherman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Gerrit Deboer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Wen Shi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Eiji Miyoshi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jorge Filmus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

89-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Hepatocellular carcinoma: diagnosis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Resection of hepatocellular carcinoma without preoperative tumor biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Molecular pathogenesis of human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

α-fetoprotein: Reevaluation in hepatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Alphafetoprotein: an obituary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Functions of cell surface heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Identification of a new membrane-bound heparan sulphate proteoglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Glypican-3 expression is silenced in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Glypicans in growth control and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Specificities of heparan sulphate proteoglycans in developmental processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900689-9

10.1016/S0016-5085(03)00689-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851874%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference